Detail akcie SynBiotic Rg online

Business Summary: SYNBIOTIC SE, formerly SynBiotic SE, is a Germany-based company. The Company operates in the industrial hemp and cannabis market. It invests in ventures across the value chain from cultivation and research to development (R&D), production, sales, and distribution of cannabinoid-based products. This includes pharmaceuticals, cosmetics, nutrition and supplements as well as lifestyle products. Its main focus is in the development of medical cannabis and industrial hemp markets. Medical cannabis is used for therapeutic applications with patients. Industrial hemp is used to manufacture products such as fibres, seeds, stalks, shives, and oils across various industries. The Company's major brands include Hempamed, The Hempany, Hempamed Rx among others.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, SynBiotic SE revenues increased from EUR3.9M to EUR14.3M. Net loss decreased 9% to EUR9.7M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Other Operating Expense decrease of 34% to EUR4.4M (expense), Other Operating Income increase from EUR214K to EUR580K (income).